⌘K (Command K) to search

Sign in Sign up free

Company · CIK 0001691428

UBS Oncology Impact Fund L.P.

other

Exchange

—

Entity type

other

Fiscal year end

Dec 31

Headquarters

Cayman Islands

Search features

Try:Supply chain AI investment Debt covenants

10 guest searches · Free accounts get 10 a day · No credit card

On the record

Recent filings

10 filings

Accepted (ET)
Jan 6144
Werewolf Therapeutics, Inc.0001628280-26-000951 · 350.0 KB
SEC(opens sec.gov)
Dec 29144
Werewolf Therapeutics, Inc.0001628280-25-059020 · 336.7 KB
SEC(opens sec.gov)
Dec 22144
Werewolf Therapeutics, Inc.0001628280-25-058567 · 327.4 KB
SEC(opens sec.gov)
Dec 10144
Werewolf Therapeutics, Inc.0001628280-25-056351 · 312.0 KB
SEC(opens sec.gov)
Dec 3144
Werewolf Therapeutics, Inc.0001628280-25-055072 · 298.8 KB
SEC(opens sec.gov)
Nov 24144
Werewolf Therapeutics, Inc.0001628280-25-053823 · 287.7 KB
SEC(opens sec.gov)
Nov 17144
Werewolf Therapeutics, Inc.0001628280-25-052648 · 277.3 KB
SEC(opens sec.gov)
Nov 10144
Werewolf Therapeutics, Inc.0001628280-25-051131 · 267.8 KB
SEC(opens sec.gov)
Nov 4144
Werewolf Therapeutics, Inc.0001628280-25-048931 · 44.9 KB
SEC(opens sec.gov)
Oct 30144
Werewolf Therapeutics, Inc.0001628280-25-047588 · 255.7 KB
SEC(opens sec.gov)

Insiders

No insiders on record.

Tickers

No tickers on record.

Addresses

business
399 BOYLSTON STREET SUITE 1100
BOSTON, MA, 02142
mailing
399 BOYLSTON STREET SUITE 1100
BOSTON, MA, 02142